Cytokinetics (CYTK) Short-term Investments (2016 - 2025)
Historic Short-term Investments for Cytokinetics (CYTK) over the last 15 years, with Q3 2024 value amounting to $964.8 million.
- Cytokinetics' Short-term Investments rose 11949.96% to $964.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $964.8 million, marking a year-over-year increase of 11949.96%. This contributed to the annual value of $501.8 million for FY2023, which is 3001.35% down from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Short-term Investments is $964.8 million, which was up 11949.96% from $866.6 million recorded in Q2 2024.
- In the past 5 years, Cytokinetics' Short-term Investments ranged from a high of $964.8 million in Q3 2024 and a low of $151.9 million during Q2 2020
- Moreover, its 5-year median value for Short-term Investments was $492.4 million (2022), whereas its average is $481.5 million.
- In the last 5 years, Cytokinetics' Short-term Investments soared by 12288.83% in 2021 and then tumbled by 4227.32% in 2023.
- Quarter analysis of 5 years shows Cytokinetics' Short-term Investments stood at $381.1 million in 2020, then decreased by 5.8% to $359.0 million in 2021, then skyrocketed by 99.74% to $717.0 million in 2022, then tumbled by 30.01% to $501.8 million in 2023, then soared by 92.27% to $964.8 million in 2024.
- Its Short-term Investments was $964.8 million in Q3 2024, compared to $866.6 million in Q2 2024 and $499.0 million in Q1 2024.